| abstract |
The present invention provides an oral pharmaceutical composition comprising: as an active ingredient bendamustine or a pharmaceutically acceptable ester, salt or solvate thereof, and a pharmaceutically acceptable excipient, the pharmaceutically acceptable The excipient is a pharmaceutically acceptable nonionic surfactant selected from the group consisting of polyethoxylated castor oil or derivatives thereof, and block copolymers of ethylene oxide and propylene oxide. |